Johnson & Johnson and its Janssen unit failed to adequately warn about the risk of acute kidney injury from their type 2 diabetes drug Invokana (generic: canagliflozin), according to a recent lawsuit filed in New Jersey federal court.
Free Confidential Lawsuit Evaluation: If you or a loved one has been harmed by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
May 1, 2017 – The complaint (PDF) was filed on behalf of Plaintiff Jessica Calongne, who was prescribed Invokana to treat her type 2 diabetes in April 2015. Cologne was hospitalized for several days later that month, and only a few weeks later was again hospitalized for kidney failure (end-stage renal disease or “ERSD”), according to the lawsuit.
“Defendants misrepresented that Invokana is a safe and effective treatment for type 2 diabetes mellitus when in fact the drug causes serious medical problems which require hospitalization and can lead to life threatening complications, including but not limited to diabetic ketoacidosis and its sequelae, kidney failure and its sequelae, as well as serious cardiovascular problems,” the lawsuit states. “[Plaintiff’s] injuries were preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions, and willful misrepresentations concerning the nature and safety of Invokana.”
The case joins a growing number of recent Invokana lawsuits filed in courts across the U.S., all of which raise similar allegations that J&J and Janssen failed to adequately warn about the risk of side effects from Invokana.
In June 2016, the U.S. Food & Drug Administration (FDA) required that the labeling of Invokana carry a warning indicating that the medicine may increase the risk of acute kidney injury and other severe health problems. FDA has also warned that side effects of Invokana may include diabetic ketoacidosis (DKA), a serious medical condition associated with elevated levels of acid in the blood.
Calongne’s lawsuit will be consolidated as part of multidistrict litigation No. 2750 before U.S. District Judge Brian Martinotti in the District of New Jersey. MDLs are common in pharmaceutical litigation in which multiple lawsuits are filed alleging similar injuries. They are intended to reduce duplicative discovery, avoid conflicting rulings by different judges, and to serve the convenience of both parties.
Do I Have an Invokana Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new ketoacidosis and kidney failure cases in all 50 states.
Free Case Evaluation: Again, if you were injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.